Published in Inhal Toxicol on April 01, 2008
Use of coated silver nanoparticles to understand the relationship of particle dissolution and bioavailability to cell and lung toxicological potential. Small (2013) 1.62
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev (2012) 1.55
Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol (2011) 1.52
Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cells. Toxicol Sci (2010) 1.31
A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices. Adv Pharmacol Sci (2010) 1.22
A Safer Formulation Concept for Flame-Generated Engineered Nanomaterials. ACS Sustain Chem Eng (2013) 1.17
Shape matters: effects of silver nanospheres and wires on human alveolar epithelial cells. Part Fibre Toxicol (2011) 1.14
Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine (Lond) (2011) 1.12
Toxicology and clinical potential of nanoparticles. Nano Today (2011) 1.05
Exposure of silver-nanoparticles and silver-ions to lung cells in vitro at the air-liquid interface. Part Fibre Toxicol (2013) 1.03
Amorphous nanosilica induce endocytosis-dependent ROS generation and DNA damage in human keratinocytes. Part Fibre Toxicol (2011) 1.03
Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats. Beilstein J Nanotechnol (2013) 0.99
In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines. Mutat Res (2011) 0.98
The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure. Respir Res (2009) 0.96
Subchronic inhalation toxicity of gold nanoparticles. Part Fibre Toxicol (2011) 0.95
Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles. Part Fibre Toxicol (2014) 0.95
Nanofibers offer alternative ways to the treatment of skin infections. J Biomed Biotechnol (2010) 0.92
In vivo Genotoxicity of Silver Nanoparticles after 90-day Silver Nanoparticle Inhalation Exposure. Saf Health Work (2011) 0.92
Influence of particle size on persistence and clearance of aerosolized silver nanoparticles in the rat lung. Toxicol Sci (2015) 0.92
Acute pulmonary toxicity and body distribution of inhaled metallic silver nanoparticles. Toxicol Res (2012) 0.90
Toxicity Effect of Silver Nanoparticles on Mice Liver Primary Cell Culture and HepG2 Cell Line. Iran J Pharm Res (2014) 0.89
Pulmonary toxicity of instilled silver nanoparticles: influence of size, coating and rat strain. PLoS One (2015) 0.89
Genotoxicity and molecular response of silver nanoparticle (NP)-based hydrogel. J Nanobiotechnology (2012) 0.88
Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation. Toxicol In Vitro (2015) 0.88
Nanotoxicity overview: nano-threat to susceptible populations. Int J Mol Sci (2014) 0.86
Short versus long silver nanowires: a comparison of in vivo pulmonary effects post instillation. Part Fibre Toxicol (2014) 0.86
Prospective environmental life cycle assessment of nanosilver T-shirts. Environ Sci Technol (2011) 0.86
In vivo human time-exposure study of orally dosed commercial silver nanoparticles. Nanomedicine (2013) 0.85
Mimicking exposures to acute and lifetime concentrations of inhaled silver nanoparticles by two different in vitro approaches. Beilstein J Nanotechnol (2014) 0.85
A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles. Int J Nanomedicine (2013) 0.85
Toxicity of silver nanoparticles at the air-liquid interface. Biomed Res Int (2012) 0.84
Sub-acute intravenous administration of silver nanoparticles in male mice alters Leydig cell function and testosterone levels. Reprod Toxicol (2014) 0.83
Differential nanoreprotoxicity of silver nanoparticles in male somatic cells and spermatogonial stem cells. Int J Nanomedicine (2015) 0.83
Modeling Population Exposures to Silver Nanoparticles Present in Consumer Products. J Nanopart Res (2014) 0.83
Systemic and behavioral effects of intranasal administration of silver nanoparticles. Neurotoxicol Teratol (2015) 0.82
Inhalation of silver nanomaterials--seeing the risks. Int J Mol Sci (2014) 0.80
Transfer of Silver Nanoparticles through the Placenta and Breast Milk during in vivo Experiments on Rats. Acta Naturae (2013) 0.80
Genotoxicity study of silver nanoparticles in bone marrow cells of Sprague-Dawley rats. Food Chem Toxicol (2015) 0.79
Engineered metal based nanoparticles and innate immunity. Clin Mol Allergy (2015) 0.78
Aerosolized Silver Nanoparticles in the Rat Lung and Pulmonary Responses over Time. Toxicol Pathol (2016) 0.77
Hormesis effects of silver nanoparticles at non-cytotoxic doses to human hepatoma cells. PLoS One (2014) 0.77
Histopathological and ultra structural effects of nanoparticles on rat testis following 90 days (Chronic study) of repeated oral administration. J Nanobiotechnology (2014) 0.76
Silver Nanoparticle-Directed Mast Cell Degranulation Is Mediated through Calcium and PI3K Signaling Independent of the High Affinity IgE Receptor. PLoS One (2016) 0.76
Mechanisms of nanosilver-induced toxicological effects: more attention should be paid to its sublethal effects. Nanoscale (2015) 0.76
Use of a modified GreenScreen tool to conduct a screening-level comparative hazard assessment of conventional silver and two forms of nanosilver. Environ Health (2016) 0.75
Pulmonary effects of inhalation of spark-generated silver nanoparticles in Brown-Norway and Sprague-Dawley rats. Respir Res (2016) 0.75
Mechanistic understanding of toxicity from nanocatalysts. Int J Mol Sci (2014) 0.75
Inactivation, Clearance, and Functional Effects of Lung-Instilled Short and Long Silver Nanowires in Rats. ACS Nano (2017) 0.75
Use of Autometallography in Studies of Nanosilver Distribution and Toxicity. Int J Toxicol (2015) 0.75
Negatively charged silver nanoparticles cause retinal vascular permeability by activating plasma contact system and disrupting adherens junction. Nanotoxicology (2015) 0.75
Tissue-engineered lungs for in vivo implantation. Science (2010) 5.90
Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest (2006) 3.66
Distribution of eschars on the body of scrub typhus patients: a prospective study. Am J Trop Med Hyg (2007) 3.36
Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facility. Inhal Toxicol (2008) 2.59
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study. J Clin Oncol (2007) 2.39
Pneumoconiosis: comparison of imaging and pathologic findings. Radiographics (2006) 2.35
Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol (2008) 2.25
Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci (2008) 2.22
Exposure assessment of carbon nanotube manufacturing workplaces. Inhal Toxicol (2010) 2.22
Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology (2005) 2.19
Proximal dominant hereditary motor and sensory neuropathy with proximal dominance association with mutation in the TRK-fused gene. JAMA Neurol (2013) 2.07
Viral pneumonias in adults: radiologic and pathologic findings. Radiographics (2002) 2.02
Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers (2012) 2.00
Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol (2009) 1.92
Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. AJR Am J Roentgenol (2003) 1.86
Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-section CT and histopathologic findings. Radiology (2004) 1.78
Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol (2007) 1.74
The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett (2009) 1.71
Creating alignment and anisotropy in engineered heart tissue: role of boundary conditions in a model three-dimensional culture system. Tissue Eng (2003) 1.69
Clinical features of recently diagnosed pulmonary paragonimiasis in Korea. Chest (2005) 1.68
Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer. J Clin Oncol (2012) 1.67
Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol (2010) 1.67
Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice. J Microbiol (2007) 1.67
Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer (2013) 1.67
Bilateral bronchiectasis and bronchiolitis at thin-section CT: diagnostic implications in nontuberculous mycobacterial pulmonary infection. Radiology (2005) 1.66
Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings. Radiographics (2006) 1.66
Thrombotic and nonthrombotic pulmonary arterial embolism: spectrum of imaging findings. Radiographics (2003) 1.61
Marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue: imaging findings in 21 patients. Chest (2007) 1.61
Molecular modeling of 3-arylisoquinoline antitumor agents active against A-549. A comparative molecular field analysis study. Bioorg Med Chem (2002) 1.59
Usefulness of nested PCR for the diagnosis of scrub typhus in clinical practice: A prospective study. Am J Trop Med Hyg (2006) 1.57
High-detectivity multilayer MoS(2) phototransistors with spectral response from ultraviolet to infrared. Adv Mater (2012) 1.54
Diagnostic performance of the cytomegalovirus (CMV) antigenemia assay in patients with CMV gastrointestinal disease. Clin Infect Dis (2009) 1.53
Optimal duration of IV and oral antibiotics in the treatment of thoracic actinomycosis. Chest (2005) 1.53
Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology (2003) 1.49
Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Ann Surg Oncol (2010) 1.47
Evaluation of liver and thyroid toxicity in Sprague-Dawley rats after exposure to polybrominated diphenyl ether BDE-209. J Toxicol Sci (2010) 1.46
Tracheal metastasis of lung cancer: CT findings in six patients. AJR Am J Roentgenol (2006) 1.45
Matched-pair analysis comparing the outcomes of T cell/histiocyte-rich large B cell lymphoma and diffuse large B cell lymphoma in patients treated with rituximab-CHOP. Acta Haematol (2013) 1.45
Proteomic identification of annexins, calcium-dependent membrane binding proteins that mediate osmotic stress and abscisic acid signal transduction in Arabidopsis. Plant Cell (2004) 1.44
Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population. J Rheumatol (2013) 1.44
AIMP1 deficiency enhances airway hyperreactivity in mice via increased TH2 immune responses. Clin Immunol (2012) 1.43
Recurrent exposure to welding fumes induces insufficient recovery from inflammation. Inhal Toxicol (2009) 1.42
A magnetic switch for the control of cell death signalling in in vitro and in vivo systems. Nat Mater (2012) 1.40
Tuberculous lymphadenitis of the thorax: comparisons of imaging findings between patients with and those without HIV infection. AJR Am J Roentgenol (2012) 1.39
Clinical usefulness of eschar polymerase chain reaction for the diagnosis of scrub typhus: a prospective study. Clin Infect Dis (2006) 1.36
A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol Methods (2002) 1.30
Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol (2013) 1.30
Incidence of hip fractures in Korea. J Bone Miner Metab (2008) 1.30
Novel transcription coactivator complex containing activating signal cointegrator 1. Mol Cell Biol (2002) 1.29
Pediatric obstructive sleep apnea syndrome. Arch Pediatr Adolesc Med (2005) 1.27
The spectrum of benign esophageal lesions: imaging findings. Korean J Radiol (2002) 1.27
Bronchial and nonbronchial systemic arteries in patients with hemoptysis: depiction on MDCT angiography. AJR Am J Roentgenol (2006) 1.24
Incidence, characteristics, and outcomes of Staphylococcus lugdunensis bacteremia. J Clin Microbiol (2010) 1.23
MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet Genomics (2007) 1.23
Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol (2011) 1.22
Cystic fibrosis in Korean children:a case report identified by a quantitative pilocarpine iontophoresis sweat test and genetic analysis. J Korean Med Sci (2005) 1.21
Diagnosis of gastric epithelial neoplasia: Dilemma for Korean pathologists. World J Gastroenterol (2011) 1.20
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer. BMC Cancer (2006) 1.20
Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy. Am J Respir Crit Care Med (2008) 1.19
Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. Toxicol Lett (2007) 1.18
Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation. Mol Cancer Ther (2012) 1.16
A highly sensitive and selective diagnostic assay based on virus nanoparticles. Nat Nanotechnol (2009) 1.15
Thin-section CT findings of nontuberculous mycobacterial pulmonary diseases: comparison between Mycobacterium avium-intracellulare complex and Mycobacterium abscessus infection. J Korean Med Sci (2005) 1.14
Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol (2010) 1.14
Neural correlates of interval timing in rodent prefrontal cortex. J Neurosci (2013) 1.13
Integrated PET/CT of salivary gland type carcinoma of the lung in 12 patients. AJR Am J Roentgenol (2007) 1.13
Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect (2009) 1.13
Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int J Nanomedicine (2012) 1.13